ghk-cu clinical trial human Frontiers ghk cu clinical trial wound
Description
Wszystkie badania s przeprowadzane przez niezalene europejskie laboratoria, co gwarantuje najwysze standardy dokadnoci i rzetelnoci
However, its associations with a pro-metastatic phenotype and therapy resistance make it an attractive target especially in tumor types characterized by highly aggressive behavior, short survival, and absence of effective treatment options
Other studies suggest analgesic effects comparable to those of placebo [126,131,132,133]
One particular study indicated that GHK-Cu might decrease iron release by 87%, which might lower oxidation levels in damaged tissues
In This Episode, We Cover: The science and benefits of BPC 157 and other therapeutic peptides
doi: 10.1016/j.ajhg.2015.05.019
